1. Review the existing data on aging in patients with sickle cell disease
  2. Discuss the gaps in knowledge regarding quality of life and mental health outcomes in older adults with sickle cell disease
  3. Detail academic plans and propose research projects


  1. Describe the effectiveness of salvage chemotherapy for DLBCL in the modern era
  2. Describe the role of 9p24.1 amplifications and translocations in immune escape in DLBCL3.
  3. Understand the rationale for investigating the connections between genomic alterations and immune escape mechanisms in DLBCL
Session date: 
10/01/2018 - 12:00pm to 1:00pm CDT
5841 South Maryland Avenue
MC2115 HemOnc Conference Room E215
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Marquita Nelson, MD and Michael J. Leukam, MD